0002022224-26-000001.txt : 20260506 0002022224-26-000001.hdr.sgml : 20260506 20260506134251 ACCESSION NUMBER: 0002022224-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260506 DATE AS OF CHANGE: 20260506 EFFECTIVENESS DATE: 20260506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mitera Biosciences Inc. CENTRAL INDEX KEY: 0002022224 ORGANIZATION NAME: EIN: 852006436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-583061 FILM NUMBER: 26947467 BUSINESS ADDRESS: STREET 1: 3120 139TH AVENUE SOUTHEAST STREET 2: SUITE 500 CITY: BELLEVUE STATE: WA ZIP: 98005 BUSINESS PHONE: 425-818-5036 MAIL ADDRESS: STREET 1: 3120 139TH AVENUE SOUTHEAST STREET 2: SUITE 500 CITY: BELLEVUE STATE: WA ZIP: 98005 D 1 primary_doc.xml X0708 D LIVE 0002022224 Mitera Biosciences Inc. 3120 139th Avenue Southeast Suite 500 Bellevue WA WASHINGTON 98005 425-818-5036 DELAWARE None None Corporation true Kevin Chow c/o Mitera Biosciences Inc. 3120 139th Avenue Southeast, Suite 500 Bellevue WA WASHINGTON 98005 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2026-04-21 false true true true Simple Agreement for Future Equity false 0 3000000 1100000 1900000 false 2 0 0 0 false Mitera Biosciences Inc. /s/ Kevin Chow Kevin Chow Chief Executive Officer 2026-05-06